Lars Olof Hedbys
Director/Board Member at CHOSA ONCOLOGY AB
Profile
Dr. Lars Olof Hedbys is an Independent Director at Xintela AB, a Partner at Ventac Partners A/S, a Partner at Ventac Partners GmbH, a Chairman at Asgard Therapeutics AB, a Chairman at Strominnate Therapeutics AB, a Chairman at Vetiqure AB, a Chief Executive Officer & Director at Vagnlyftaren AB and a Director & Partner at Ventac Partners AB.
He is on the Board of Directors at Chosa Oncology AB, Xintela AB, Vagnlyftaren AB, CanImGuide Therapeutics AB, Immodulate Pharma AB, Cell Invent AB, Cell Invent Sweden AB and Ventac Partners AB.
Dr. Hedbys was previously employed as a Chairman by Scandinavian ChemoTech AB, a Chairman by Smile Incubator AB, a Chief Executive Officer by Glycorex Transplantation AB, a Director & IR Contact by Idogen AB, a Vice President & General Manager by Astrazeneca Alpha BV, a Chairman by Iampatient AB, a Chairman by Lund Life Science Incubator, a Chief Executive Officer by Mando AB, a Chief Executive Officer by Pharmiva AB, a General Manager by Synarc A/S, and a Senior Advisor by Ventac Partners LLC.
He also served on the board at Hamlet BioPharma AB, RhoVac AB, Cartela AB and Regenesance BV.
He received his graduate degree from Chalmers University of Technology and a doctorate degree from Faculty of Engineering, Lund University.
Lars Olof Hedbys active positions
Companies | Position | Start |
---|---|---|
XINTELA AB | Director/Board Member | 2020-12-31 |
CHOSA ONCOLOGY AB | Director/Board Member | 2022-12-31 |
Immodulate Pharma AB | Director/Board Member | - |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Director/Board Member | - |
Ventac Partners AB | Director/Board Member | - |
Vetiqure AB | Chairman | - |
Strominnate Therapeutics AB
Strominnate Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Strominnate Therapeutics AB is a Swedish company that offers effective treatments for tumors and conditions of the nervous system. The company is based in Lund, Sweden. The company was founded in 2021 by Tania Ramos Moreno, who is also the CEO of the company and a guest researcher at the Stem Cell Center in Lund University. The company provides a new product as a novel therapy for treating Glioblastoma multiforme, the most common and malignant brain tumor in adults. The product contains the antitumoral components and the environment modulators produced by a recently discovered human immune cell. | Chairman | - |
Cell Invent AB | Director/Board Member | - |
Asgard Therapeutics AB
Asgard Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Asgard Therapeutics AB engages in biotechnological research and development activities. It is in use of cellular reprogramming in cancer immunotherapy, which forces cancer cells to present their own antigens to the immune system, triggering expansion of cancer cell-specific killer T cells and cancer elimination. The company was founded by Filipe Pereira, Cristiana Pires and Fábio Rosa in 2018 and is headquartered in Lund, Sweden. | Chairman | - |
░░░░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Former positions of Lars Olof Hedbys
Companies | Position | End |
---|---|---|
░░░░░░░░░░░░ ░░░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Lars Olof Hedbys
Chalmers University of Technology | Graduate Degree |
Faculty of Engineering, Lund University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 7 |
---|---|
GLYCOREX TRANSPLANTATION AB | Health Technology |
XINTELA AB | Health Technology |
IDOGEN AB (PUBL) | Health Technology |
HAMLET PHARMA AB (PUBL) | Health Technology |
PHARMIVA AB (PUBL) | Commercial Services |
SCANDINAVIAN CHEMOTECH AB | Health Technology |
CHOSA ONCOLOGY AB | Commercial Services |
Private companies | 21 |
---|---|
Cartela AB
Cartela AB Pharmaceuticals: MajorHealth Technology Cartela AB develops therapies for arthritic diseases. It products are mainly used by osteoarthritis and rheumatoid arthritis. Its business is based on the cell surface molecules, integrants a10ß1 and a11ß1. The company was founded by Evy Lundgren-Åkerlund and Donald Gullberg in 2000 and is headquartered in Lund, Sweden. | Health Technology |
Mando AB
Mando AB Medical/Nursing ServicesHealth Services Mando AB engages in the provision of health care services. It offers treatment for anorexia nervosa and bulimia nervosa as well as other eating disorders using Mandometer Method. The company was founded in 2000 and is headquartered in Huddinge, Sweden. | Health Services |
Ventac Partners GmbH
Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Ventac Partners GMBH offers life sciences consultancy services. Its consulting services include due diligence, education and training, market analysis, product development and valuation. The company was founded by Mikael Oerum in 2002 and is headquartered in Munich, Germany. | Commercial Services |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
Synarc A/S | |
Astrazeneca Alpha BV | |
Regenesance BV
Regenesance BV Drugstore ChainsRetail Trade Regenesance BV develops drugs for the treatment of neurodegenerative and immune mediated disorders. Its products include Regenemab, a monoclonal antibody for multiple indications like PNH, myasthenia gravis, amyotrophic lateral sclerosis, and multiples sclerosis. The company was founded by Valeria Ramaglia, Mikael Orum, Frank Baas and Kees Fluiter in 2009 is headquartered in Amsterdam, the Netherlands. | Retail Trade |
Ventac Partners LLC | |
Ventac Partners A/S
Ventac Partners A/S Miscellaneous Commercial ServicesCommercial Services Part of Ventac Partners GmbH, Ventac Partners A/S provides life science consulting services. The private company is based in Copenhagen, Denmark. The CEO of the Danish company is Mikael Ørum. | Commercial Services |
Lund Life Science Incubator | |
Vagnlyftaren AB | |
RhoVac AB
RhoVac AB BiotechnologyHealth Technology RhoVac AB opertaes as biotechnology company that engages in the research and development of immunotherapy. The firm develops therapeutic cancer vaccines. Its main focus is the development of a drug with the potential to prevent or limit the metastasis of metastatic cancers. The company was founded by Bo Anders Ljungqvist, Per Thor Straten, and Mads Hald Andersen in November 2015 and is headquartered in Lund, Sweden. | Health Technology |
Iampatient AB
Iampatient AB Packaged SoftwareTechnology Services Iampatient AB develops a mobile application that assists patients with chronic diseases in managing their medication. The private company is based in Lund, Sweden. The Swedish company was founded by Lars Olof Hedbys. | Technology Services |
Smile Incubator AB
Smile Incubator AB Miscellaneous Commercial ServicesCommercial Services Smile Incubator AB is a non-profit business incubator that focuses on helping life science entrepreneurs to commercialize their innovations. Smile Incubator is based in Lund, SE. The Swedish company's main goal is to enable better health through the development of new technologies and products. Ebba Cecilia FÃ¥hraeus has been the CEO of the private company since 2015. | Commercial Services |
Asgard Therapeutics AB
Asgard Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Asgard Therapeutics AB engages in biotechnological research and development activities. It is in use of cellular reprogramming in cancer immunotherapy, which forces cancer cells to present their own antigens to the immune system, triggering expansion of cancer cell-specific killer T cells and cancer elimination. The company was founded by Filipe Pereira, Cristiana Pires and Fábio Rosa in 2018 and is headquartered in Lund, Sweden. | Commercial Services |
Immodulate Pharma AB | |
Cell Invent AB | |
Strominnate Therapeutics AB
Strominnate Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Strominnate Therapeutics AB is a Swedish company that offers effective treatments for tumors and conditions of the nervous system. The company is based in Lund, Sweden. The company was founded in 2021 by Tania Ramos Moreno, who is also the CEO of the company and a guest researcher at the Stem Cell Center in Lund University. The company provides a new product as a novel therapy for treating Glioblastoma multiforme, the most common and malignant brain tumor in adults. The product contains the antitumoral components and the environment modulators produced by a recently discovered human immune cell. | Commercial Services |
Vetiqure AB | |
Ventac Partners AB | |
Cell Invent Sweden AB
Cell Invent Sweden AB Miscellaneous Commercial ServicesCommercial Services Cell Invent Sweden AB is a company based in Lund, Sweden that develops new human disease models based on reprogrammed Alzheimer patient cells. The Swedish company is developing phenotype-based screening methods for drug discovery, drug development, and companion diagnostics development. The company was founded in 2019 by Håkan Toresson, Camilla Orbjörn, Lennart Minthon, Oskar Hansson, and Håkan Toresson has been the CEO since 2019. | Commercial Services |
- Stock Market
- Insiders
- Lars Olof Hedbys